Pharmacological blockage and P2X7 deletion hinder aversive memories: reversion in an enriched environment

R C Campos1, G M Parfitt1, C E Polese2

  • 1Programa de Pós-graduação em Ciências Fisiológicas - Fisiologia Animal Comparada, Instituto de Ciências Biológicas, Laboratório de Neurociências, Universidade Federal do Rio Grande (FURG), Rio Grande, RS 96203-900, Brazil.

Neuroscience
|September 21, 2014
PubMed

Insights

The P2X7 receptor (P2X7R) is crucial for aversive memory. Blocking or deleting P2X7R impairs memory, but environmental enrichment can reverse these deficits.

Area of Science:

  • Neuroscience
  • Cell Signaling
  • Molecular Biology

Background:

  • Adenosine triphosphate (ATP) is a key signaling molecule.
  • ATP activates P2X and P2Y receptors, influencing neuronal and glial cells.
  • ATP release is implicated in hippocampal long-term potentiation (LTP).

Purpose of the Study:

  • Investigate the role of P2X7 receptor (P2X7R) in aversive memory.
  • Examine P2X7R function using knockout mice and pharmacological blockade in rats.
  • Evaluate the impact of environmental enrichment on P2X7R-related memory deficits.

Main Methods:

  • Contextual fear-conditioning (FC) paradigm in rats and mice.
  • Pharmacological blockade of P2X7R using A-740003 in rats.
  • Utilized P2X7R knockout (KO) mice.
  • Assessed habituation memory.

Main Results:

  • Pharmacological P2X7R blockade impaired memory acquisition, consolidation, and retrieval in rats.
  • P2X7R deletion in mice also hampered aversive memory processes.
  • Environmental enrichment reversed mnemonic impairments in P2X7R KO mice.
  • No alterations in habituation memory were observed in P2X7R KO mice.

Conclusions:

  • P2X7R plays a significant role in aversive memory formation and retrieval.
  • Environmental enrichment can mitigate P2X7R-dependent memory deficits.
  • P2X7R is not involved in the memory reversal effects of environmental enrichment.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
3.5K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.5K
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.3K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
767